scispace - formally typeset
I

Irene Oi-Lin Ng

Researcher at University of Hong Kong

Publications -  441
Citations -  33342

Irene Oi-Lin Ng is an academic researcher from University of Hong Kong. The author has contributed to research in topics: Hepatocellular carcinoma & Cancer. The author has an hindex of 95, co-authored 414 publications receiving 29301 citations. Previous affiliations of Irene Oi-Lin Ng include National University of Singapore & Royal Free Hospital.

Papers
More filters
Journal ArticleDOI

Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

TL;DR: In this paper, the authors identify, isolate, and characterize the CSC population that drives and maintains hepatocellular carcinoma (HCC) growth and metastasis using a severe partial hepatectomy model.
Journal ArticleDOI

RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2

TL;DR: Methyltransferase‐like 3 (METTL3), a major RNA N6‐adenosine methyltransferase, was significantly up‐regulated in human hepatocellular carcinoma (HCC) and multiple solid tumors and suggest an important mechanism of epigenetic alteration in liver carcinogenesis.
Journal ArticleDOI

Gene expression patterns in human liver cancers.

TL;DR: Using cDNA microarrays to characterize patterns of gene expression in Hepatocellular carcinoma, consistent differences between the expression patterns in HCC compared with those seen in nontumor liver tissues are found.
Journal ArticleDOI

MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer

TL;DR: The expression patterns of microRNAs in liver tissue differ between men and women with hepatocellular carcinoma, and the miR-26 expression status of such patients is associated with survival and response to adjuvant therapy with interferon alfa.
Journal ArticleDOI

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years.

TL;DR: Significant improvement of overall and disease-free survival results after resection of HCC has been achieved within the past decade as a result of advances in the diagnosis and surgical management of H CC.